| pubmed-article:7572755 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C1512288 | lld:lifeskim |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C0280631 | lld:lifeskim |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:7572755 | lifeskim:mentions | umls-concept:C0092419 | lld:lifeskim |
| pubmed-article:7572755 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7572755 | pubmed:dateCreated | 1995-11-3 | lld:pubmed |
| pubmed-article:7572755 | pubmed:abstractText | Aminothiadiazole was used to treat 21 patients with metastatic or recurrent leiomyosarcoma of the uterus. All patients received a starting dose of aminothiadiazole of 125 mg/m2 intravenously (30-to-45-minute infusion), which was repeated at weekly intervals. All patients also took allopurinol 300 mg per day orally to prevent hyperuricemia, a side effect of aminothiadiazole. Five patients (25%) had stable disease but there were no objective responses. Toxicity was generally mild with this regimen. There was no life-threatening toxicity and only three episodes of severe toxicity. One patient experienced both grade 3 leukopenia and thrombocytopenia, while another patient had grade 3 nausea and vomiting. Further studies in this disease are not planned. | lld:pubmed |
| pubmed-article:7572755 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7572755 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7572755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7572755 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7572755 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7572755 | pubmed:issn | 0277-3732 | lld:pubmed |
| pubmed-article:7572755 | pubmed:author | pubmed-author:SmithD MDM | lld:pubmed |
| pubmed-article:7572755 | pubmed:author | pubmed-author:BlessingJ AJA | lld:pubmed |
| pubmed-article:7572755 | pubmed:author | pubmed-author:CarsonL FLF | lld:pubmed |
| pubmed-article:7572755 | pubmed:author | pubmed-author:AsburyRR | lld:pubmed |
| pubmed-article:7572755 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7572755 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:7572755 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7572755 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7572755 | pubmed:pagination | 397-9 | lld:pubmed |
| pubmed-article:7572755 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:meshHeading | pubmed-meshheading:7572755-... | lld:pubmed |
| pubmed-article:7572755 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7572755 | pubmed:articleTitle | Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study. | lld:pubmed |
| pubmed-article:7572755 | pubmed:affiliation | Department of Oncology, University of Rochester School of Medicine, NY, USA. | lld:pubmed |
| pubmed-article:7572755 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7572755 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7572755 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7572755 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
